Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on improving patients’ lives by Overcoming Resistance In Cancer. The Company is advancing a diverse pipeline of clinical and discovery stage therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. The Company's clinical-stage product candidates include ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and ORIC-114, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers. In addition, the Company is also developing multiple discovery stage precision medicines targeting other hallmark cancer resistance mechanisms. Its out-licensing candidates include ORIC-533 and ORIC-613.
Find out what a historical investment in ORIC Pharmaceuticals would be worth today using our ORIC stock calculator.
Buying ORIC shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ORIC Pharmaceuticals in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in ORIC
What is the ticker symbol of ORIC Pharmaceuticals?
The ticker symbol for ORIC Pharmaceuticals is ORIC.
How much is one share of ORIC?
One share of ORIC is valued at $7.36 as of 22 November 2026.
What is the market capitalisation of ORIC Pharmaceuticals ORIC?
As of 22 November 2026 ORIC Pharmaceuticals has a market cap of $764.94M.
What is the 52-week high for ORIC Pharmaceuticals stock?
The ORIC Pharmaceuticals 52-week high stock price is $14.68.
What is the 52-week low for ORIC Pharmaceuticals stock?
The ORIC Pharmaceuticals 52-week low stock price is $7.23.
Can I buy ORIC shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ORIC shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ORIC on Stake
Buy ORIC from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of ORIC from only US$10 with fractional shares